During the past decade, University of Chicago Department of Medicine conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Chicago Department of Medicine" #1 sponsor was "Actelion" with 1 trials, followed by "Interscope, Inc." with 1 trials sponsored, "Savient Pharmaceuticals" with 1 trials sponsored, "Sunovion" with 1 trials sponsored and "Synta Pharmaceuticals Corp." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "University of Chicago Department of Medicine" are "Acute Pancreatic Necrosis" (1 trials), "Acute Pancreatitis" (1 trials), "Chronic Bronchitis" (1 trials), "Chronic Obstructive Pulmonary Disease" (1 trials) and "Clostridium Difficile Infection" (1 trials). Many other conditions were trialed in "University of Chicago Department of Medicine" in a lesser frequency.

Most popular intervention types in "University of Chicago Department of Medicine" are "Drug" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cadazolid" (1 trials), "EndoRotor Therapy" (1 trials), "Puricase" (1 trials), "STA-4783" (1 trials) and "Salmeterol" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Chicago Department of Medicine" are 5 trials for "All" genders.

Currently, there are NaN active trials in "University of Chicago Department of Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in University of Chicago Department of Medicine, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Chicago Department of Medicine, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".